Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Adaptimmune Ther Ads (NASDAQ: ADAP)

$5.56 USD $0.00 (0.00%)
Last Price $5.56
Net Change $0 (0%)
Bid $0
Ask Price $0
Open Price $5.57
Previous Close Price $5.56
High Price $5.67
Low Price $5.48
Number of Trades 661
Volume 155,726
Fifty Two Week High $11.59 (2016-06-06)
Fifty Two Week Low $3.76 (2016-12-15)
Average Daily Volume 218,995
Share Outstanding 70,790 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0.79
Recent Earnings $
Annual EPS $-0.81
Last Quarter EPS $
Market Capitalization $0.39B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 70,790
Inst. Shareholder % 42.01%
Annual Net Income $0B
TTM Net Profit Margin $100.67
1-Year Return -41.16%
3-Year Return -65.25%
5-Year Return -65.25%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 0.79%
Dividends per Share $
Stock Split Ratio
Beta 1.25
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.

No News found for ADAP